Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to improve cardiovascular and renal outcomes in patients with established cardiovascular disease, chronic kidney disease (CKD), and heart failure (HF) with reduced or preserved ejection fraction. Clinical benefit has been substantia...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastogi, Anjay, Januzzi, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143176/
https://www.ncbi.nlm.nih.gov/pubmed/37109162
http://dx.doi.org/10.3390/jcm12082824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143176/
https://www.ncbi.nlm.nih.gov/pubmed/37109162
http://dx.doi.org/10.3390/jcm12082824

Ejemplares similares